FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Viktor Umansky

Research Profile

Living Beings

Anatomy

Physiology

Immunologic Memory

Procedures

Phenomena

Tumor Microenvironment

Disorders

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Alexandra Sevko; Ludmila Umansky; Michal Baniyash; Christine S Falk; Julia Kanterman; Masashi Kato; Tillmann Michels; Marcel Ramacher; Moshe Sade-Feldman; Dirk Schadendorf; Viktor Umansky
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
Alexandra Sevko; Galina V Shurin; Michael R Shurin; Ludmila Umansky; Philipp Beckhove; Masashi Kato; Tillmann Michels; Melissa Vrohlings; Viktor Umansky
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Alexandra Sevko; Viktor Umansky
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Viktor Umansky (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Alexandra Sevko; Ludmila Umansky; Michal Baniyash; Christine S Falk; Julia Kanterman; Masashi Kato; Tillmann Michels; Marcel Ramacher; Moshe Sade-Feldman; Dirk Schadendorf; Viktor Umansky
Cyclophosphamide promotes chronic inflammation-dependent immunosuppression and prevents antitumor response in melanoma.
The Journal of investigative dermatology 2013;133(6):1610-9.
2013: Alexandra Sevko; Galina V Shurin; Michael R Shurin; Ludmila Umansky; Philipp Beckhove; Masashi Kato; Tillmann Michels; Melissa Vrohlings; Viktor Umansky
Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model.
Journal of immunology (Baltimore, Md. : 1950) 2013;190(5):2464-71.
2013: Alexandra Sevko; Viktor Umansky
Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: thick as thieves.
Journal of Cancer 2013;4(1):3-11.
2012: Eva Schlecker; Ana Stojanovic; Viktor Umansky; Christian Eisen; Christine S Falk; Christian Quack; Adelheid Cerwenka
Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
Journal of immunology (Baltimore, Md. : 1950) 2012;189(12):5602-11.
2012: Pedro Berraondo; Viktor Umansky; Ignacio Melero
Changing the tumor microenvironment: new strategies for immunotherapy.
Cancer research 2012;72(20):5159-64.
2012: Viktor Umansky
Immunosuppression in the tumor microenvironment: where are we standing?
Seminars in cancer biology 2012;22(4):273-4.
2012: Viktor Umansky; Alexandra Sevko
Melanoma-induced immunosuppression and its neutralization.
Seminars in cancer biology 2012;22(4):319-26.
2012: Anatoli Malyguine; Natalia Aptsiauri; Beatrix Kotlan; Viktor Umansky; Michael R Shurin
Conference overview: Cancer Immunotherapy and Immunomonitoring (CITIM): moving forward.
Journal of immunotoxicology 2012;9(3):231-5.
2012: Alexandra Sevko; Galina V Shurin; Michael R Shurin; Ludmila Umansky; Christine Falk; Veronika Kremer; Viktor Umansky
Application of paclitaxel in low non-cytotoxic doses supports vaccination with melanoma antigens in normal mice.
Journal of immunotoxicology 2012;9(3):275-81.
2012: Tillmann Michels; Hiam Naiditch; Alexandra Sevko; Galina V Shurin; Viktor Umansky; Michael R Shurin
Paclitaxel promotes differentiation of myeloid-derived suppressor cells into dendritic cells in vitro in a TLR4-independent manner.
Journal of immunotoxicology 2012;9(3):292-300.
2012: Ivan Shevchenko; Alexandr V Bazhin; Viktor Umansky
Comment on "Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b(+)Gr1(+) cells".
Journal of immunology (Baltimore, Md. : 1950) 2012;188(7):2929-30; author reply 1930.
2012: Viktor Umansky; Alexandra Sevko
Overcoming immunosuppression in the melanoma microenvironment induced by chronic inflammation.
Cancer immunology, immunotherapy : CII 2012;61(2):275-82.
2012: Viktor Umansky; Natalia Aptsiauri; Beatrix Kotlan; Anatoli Malyguine; Michael R Shurin
From cell regulation to patient survival: 2nd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, Budapest, 2-5 May 2011.
Cancer immunology, immunotherapy : CII 2012;61(2):295-301.
2011: Christiane Meyer; Wolfram Osen; Marcel Ramacher; Dirk Schadendorf; Alexandra Sevko; Michal Baniyash; Alexandr V Bazhin; Ivan Borrello; Christine S Falk; Masashi Kato; Viktor Umansky
Chronic inflammation promotes myeloid-derived suppressor cell activation blocking antitumor immunity in transgenic mouse melanoma model.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(41):17111-6.
2010: Viktor Umansky; Barbara-ann Guinn
ESCII-PIVAC meeting "Recent advances in cancer immunotherapy with an emphasis on cancer vaccines" held in Athens, 9-11 October 2008.
Cancer immunology, immunotherapy : CII 2010;59(4):635-40.
2010: Viktor Umansky
The 3rd International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): meeting highlights. 11-13 November, 2009, Dublin, Ireland.
Immunotherapy 2010;2(2):151-4.
2010: Alexandr V Bazhin; Sarah Kahnert; Silvia Kimpfler; Dirk Schadendorf; Viktor Umansky
Distinct metabolism of cyclic adenosine monophosphate in regulatory and helper CD4+ T cells.
Molecular immunology 2010;47(4):678-84.
2009: Silvia Kimpfler; Alexandra Sevko; Sabine Ring; Christine Falk; Wolfram Osen; Kathrin Frank; Masashi Kato; Karsten Mahnke; Dirk Schadendorf; Viktor Umansky
Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(10):6330-7.
2009: Marcel Ramacher; Viktor Umansky; Thomas Efferth
Effect of artesunate on immune cells in ret-transgenic mouse melanoma model.
Anti-cancer drugs 2009;20(10):910-7.
2009: Viktor Umansky; Anatoli Malyguine; Michael Shurin
New perspectives in cancer immunotherapy and immunomonitoring.
Future oncology (London, England) 2009;5(7):941-4.
2009: Fang Zhao; Christine Falk; Wolfram Osen; Masashi Kato; Dirk Schadendorf; Viktor Umansky
Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4382-90.
2009: Alexandr V Bazhin; Claudia Dalke; Nadine Willner; Oliver Abschütz; Hannes G H Wildberger; Pavel P Philippov; Reinhard Dummer; Jochen Graw; Martin Hrabé De Angelis; Dirk Schadendorf; Viktor Umansky; Stefan B Eichmüller
Cancer-retina antigens as potential paraneoplastic antigens in melanoma-associated retinopathy.
International journal of cancer. Journal international du cancer 2009;124(1):140-9.
2008: Viktor Umansky; Oliver Abschuetz; Wolfram Osen; Marcel Ramacher; Fang Zhao; Masashi Kato; Dirk Schadendorf
Melanoma-specific memory T cells are functionally active in Ret transgenic mice without macroscopic tumors.
Cancer research 2008;68(22):9451-8.
2007: Alexandr V Bazhin; Dirk Schadendorf; Nadine Willner; Charles De Smet; Anita Heinzelmann; Natalya K Tikhomirova; Viktor Umansky; Pavel P Philippov; Stefan B Eichmüller
Photoreceptor proteins as cancer-retina antigens.
International journal of cancer. Journal international du cancer 2007;120(6):1268-76.
2006: Jan Muller-Berghaus; Katrin Ehlert; Selma Ugurel; Viktor Umansky; Mariana Bucur; Volker Schirrmacher; Philipp Beckhove; Dirk Schadendorf
Melanoma-reactive T cells in the bone marrow of melanoma patients: association with disease stage and disease duration.
Cancer research 2006;66(12):5997-6001.
2004: Markus Feuerer; Philipp Beckhove; Yolanda D Mahnke; Mirja Hommel; Bruno Kyewski; Alf Hamann; Viktor Umansky; Volker Schirrmacher
Bone marrow microenvironment facilitating dendritic cell: CD4 T cell interactions and maintenance of CD4 memory.
International journal of oncology 2004;25(4):867-76.
2004: Philipp Beckhove; Markus Feuerer; Mathias Dolenc; Florian Schuetz; Carmen Choi; Nora Sommerfeldt; Jochen Schwendemann; Katrin Ehlert; Peter Altevogt; Gunther Bastert; Volker Schirrmacher; Viktor Umansky
Specifically activated memory T cell subsets from cancer patients recognize and reject xenotransplanted autologous tumors.
The Journal of clinical investigation 2004;114(1):67-76.
2003: Volker Schirrmacher; Markus Feuerer; Philippe Fournier; Thorsten Ahlert; Viktor Umansky; Philipp Beckhove
T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity.
Trends in molecular medicine 2003;9(12):526-34.
2003: Markus Feuerer; Philipp Beckhove; Natalio Garbi; Yolanda D Mahnke; Andreas Limmer; Mirja Hommel; Günter J Hämmerling; Bruno Kyewski; Alf Hamann; Viktor Umansky; Volker Schirrmacher
Bone marrow as a priming site for T-cell responses to blood-borne antigen.
Nature medicine 2003;9(9):1151-7.
2003: Philipp Beckhove; Florian Schütz; Ingo J Diel; Erich Solomayer; Gunther Bastert; Joanna Foerster; Markus Feuerer; Lianhua Bai; Hans-Peter Sinn; Viktor Umansky; Volker Schirrmacher
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice.
International journal of cancer. Journal international du cancer 2003;105(4):444-53.
2003: Erich Solomayer; Markus Feuerer; Lianhua Bai; Viktor Umansky; Philipp Beckhove; Gabriele C Meyberg; Gunther Bastert; Volker Schirrmacher; Ingo J Diel
Influence of adjuvant hormone therapy and chemotherapy on the immune system analysed in the bone marrow of patients with breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):174-80.
2003: Lianhua Bai; Philipp Beckhove; Markus Feuerer; Viktor Umansky; Carmen Choi; Florian Schütz Erich-Franz Solomayer; Ingo J Diel; Volker Schirrmacher
Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
International journal of cancer. Journal international du cancer 2003;103(1):73-83.
2002: Volker Schirrmacher; Markus Feuerer; Philipp Beckhove; Thorsten Ahlert; Viktor Umansky
T cell memory, anergy and immunotherapy in breast cancer.
Journal of mammary gland biology and neoplasia 2002;7(2):201-8.
2002: Susanne Müerköster; MA Weigand; Carmen Choi; Henning Walczak; Volker Schirrmacher; Viktor Umansky
Superantigen reactive Vbeta6+ T cells induce perforin/granzyme B mediated caspase-independent apoptosis in tumour cells.
British journal of cancer 2002;86(5):828-36.
2002: Lianhua Bai; Markus Feuerer; Philipp Beckhove; Viktor Umansky; Volker Schirrmacher
Generation of dendritic cells from human bone marrow mononuclear cells: advantages for clinical application in comparison to peripheral blood monocyte derived cells.
International journal of oncology 2002;20(2):247-53.
2001: Viktor Umansky; F Ratter; Stefan Lampel; Mariana Bucur; Volker Schirrmacher; A Ushmorov
Inhibition of nitric-oxide-mediated apoptosis in Jurkat leukemia cells despite cytochrome c release.
Experimental cell research 2001;265(2):274-82.
2001: Markus Feuerer; Philipp Beckhove; Lianhua Bai; Erich Solomayer; Gunther Bastert; Ingo J Diel; C Pedain; M Oberniedermayr; Volker Schirrmacher; Viktor Umansky
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.
Nature medicine 2001;7(4):452-8.
2001: Markus Feuerer; M Rocha; Lianhua Bai; Viktor Umansky; Erich Solomayer; Gunther Bastert; Ingo J Diel; Volker Schirrmacher
Enrichment of memory T cells and other profound immunological changes in the bone marrow from untreated breast cancer patients.
International journal of cancer. Journal international du cancer 2001;92(1):96-105.
2001: M Rocha; Volker Schirrmacher; Viktor Umansky
Dissection of tumor and host cells from metastasized organs for testing gene expression directly ex vivo.
Methods in molecular medicine 2001;58():277-84.
2000: Volker Schirrmacher; Susanne Müerköster; Mariana Bucur; Viktor Umansky; M Rocha
Breaking tolerance to a tumor-associated viral superantigen as a basis for graft-versus-leukemia reactivity.
International journal of cancer. Journal international du cancer 2000;87(5):695-706.
2000: Viktor Umansky; M Rocha; Raoul Breitkreutz; Steffen P Hehner; Mariana Bucur; N Erbe; Wulf Dröge; A Ushmorov
Glutathione is a factor of resistance of Jurkat leukemia cells to nitric oxide-mediated apoptosis.
Journal of cellular biochemistry 2000;78(4):578-87.
2000: Susanne Müerköster; J D Laman; M Rocha; Viktor Umansky; Volker Schirrmacher
Functional and in situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(5):1988-96.
2000: Volker Schirrmacher; Lianhua Bai; Viktor Umansky; L Yu; Y Xing; Z Qian
Newcastle disease virus activates macrophages for anti-tumor activity.
International journal of oncology 2000;16(2):363-73.
2000: Viktor Umansky; A Ushmorov; F Ratter; Katerina Chlichlia; Mariana Bucur; A Lichtenauer; M Rocha
Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).
International journal of oncology 2000;16(1):109-17.
1999: Susanne Müerköster; M Rocha; P R Crocker; Volker Schirrmacher; Viktor Umansky
Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia reactivity in mice.
Blood 1999;93(12):4375-86.
1999: A Ushmorov; F Ratter; Volker Lehmann; Wulf Dröge; Volker Schirrmacher; Viktor Umansky
Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release.
Blood 1999;93(7):2342-52.
1998: Susanne Müerköster; O Wachowski; Heide Zerban; Volker Schirrmacher; Viktor Umansky; M Rocha
Graft-versus-leukemia reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3095-106.
1998: Volker Schirrmacher; Susanne Müerköster; Viktor Umansky
Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2635-45.
1998: B Liliensiek; M Rocha; Viktor Umansky; Axel Benner; J Lin; R Ziegler; Peter P Nawroth; Volker Schirrmacher
Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status--a study in ex vivo-isolated endothelial cells.
Blood 1998;92(9):3394-404.
1998: Volker Schirrmacher; U Beutner; Mariana Bucur; Viktor Umansky; M Rocha; Paul von Hoegen
Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(2):563-70.
1998: Katerina Chlichlia; Marcus E Peter; M Rocha; C Scaffidi; Mariana Bucur; Peter H Krammer; Volker Schirrmacher; Viktor Umansky
Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells.
Blood 1998;91(11):4311-20.
1997: M Rocha; Viktor Umansky; K H Lee; Hans Hacker; Axel Benner; Volker Schirrmacher
Differences between graft-versus-leukemia and graft-versus-host reactivity. I. Interaction of donor immune T cells with tumor and/or host cells.
Blood 1997;89(6):2189-202.
1996: M Rocha; K Hexel; Mariana Bucur; Volker Schirrmacher; Viktor Umansky
Dissection of tumour and host cells from target organs of metastasis for testing gene expression directly ex vivo.
British journal of cancer 1996;74(8):1216-22.
1996: Viktor Umansky; Volker Schirrmacher; M Rocha
New insights into tumor-host interactions in lymphoma metastasis.
Journal of molecular medicine (Berlin, Germany) 1996;74(7):353-63.
1996: Viktor Umansky; M Rocha; Volker Schirrmacher
Liver endothelial cells: participation in host response to lymphoma metastasis.
Cancer metastasis reviews 1996;15(2):273-9.
1996: M Rocha; A Krüger; Viktor Umansky; Paul von Hoegen; D Naor; Volker Schirrmacher
Dynamic expression changes in vivo of adhesion and costimulatory molecules determine load and pattern of lymphoma liver metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):811-20.
1996: Viktor Umansky; Vladimir Shatrov; Volker Lehmann; Volker Schirrmacher
Induction of NO synthesis in macrophages by Newcastle disease virus is associated with activation of nuclear factor-kappa B.
International immunology 1996;8(4):491-8.
1996: Viktor Umansky; P Beckhove; M Rocha; A Krüger; P R Crocker; Volker Schirrmacher
A role for sialoadhesin-positive tissue macrophages in host resistance to lymphoma metastasis in vivo.
Immunology 1996;87(2):303-9.
1996: Volker Schirrmacher; Viktor Umansky; M Rocha
Immunotherapy of metastases.
Current topics in microbiology and immunology 1996;213 ( Pt 3)():189-216.
1995: M Rocha; A Krüger; N Van Rooijen; Volker Schirrmacher; Viktor Umansky
Liver endothelial cells participate in T-cell-dependent host resistance to lymphoma metastasis by production of nitric oxide in vivo.
International journal of cancer. Journal international du cancer 1995;63(3):405-11.
1994: A Krüger; Viktor Umansky; M Rocha; H J Hacker; Volker Schirrmacher; Paul von Hoegen
Pattern and load of spontaneous liver metastasis dependent on host immune status studied with a lacZ transduced lymphoma.
Blood 1994;84(9):3166-74.